Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4827-4830, Vol. 68, No. 8
Institut de Pharmacologie et de Biologie
Structurale, CNRS UPR 9062, 31077 Toulouse, France
Received 18 October 1999/Returned for modification 27 December
1999/Accepted 5 April 2000
The mycobacterial lipoarabinomannans (LAMs) are
glycosylphosphatidyl-myo-inositol-anchored lipoglycans with
diverse biological activities. It has been shown that purified LAMs
interact directly, or indirectly, through receptors with the plasma
membrane receptors of target cells located in domains rich in
glycosylphosphatidylinositol-anchored proteins that contain Src family
protein tyrosine kinases. To examine whether LAMs could activate
Src-related kinases, human neutrophils were exposed to mannosylated
LAMs (ManLAMs) purified from the vaccinal strain Mycobacterium
bovis BCG and to phosphoinositol-capped LAMs (AraLAM or PILAM)
obtained from the nonpathogenic species Mycobacterium
smegmatis. We report first that both ManLAMs and PILAMs activate
Hck in a rapid and transient manner and second that complete
deacylation of ManLAM abolished its effect on Hck activity, thereby
demonstrating that acylation of LAM but not mannosylation is critical
for Hck activation. These data indicate that Hck is involved in the
signaling pathway of LAMs, molecules known for their ability to trigger
several responses in eukaryotic cells.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Lipoarabinomannans Activate the Protein
Tyrosine Kinase Hck in Human Neutrophils
*
Corresponding author. Mailing address: Institut de
Pharmacologie et de Biologie Structurale, CNRS UPR 9062, 205 Route de
Narboune, 31077 Toulouse, France. Phone: 33 561 54 58. Fax: 33 561 59 94. E-mail: maridono{at}ipbs.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»